Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 604,363 | 421,365 | 242,493 | 235,306 | 213,421 |
| Marketable Securities | 171,349 | 277,282 | 389,564 | 433,808 | 514,623 |
| Receivables | 178,317 | 183,371 | 158,043 | 189,206 | 186,542 |
| Inventories | 130,770 | 124,092 | 118,259 | 114,699 | 115,172 |
| TOTAL | $1,173,928 | $1,091,384 | $982,257 | $1,048,506 | $1,101,633 |
| Non-Current Assets | |||||
| PPE Net | 686,602 | 684,574 | 684,756 | 670,506 | 663,653 |
| Intangibles | 4,256,807 | 4,279,716 | 4,302,280 | 4,322,870 | 4,392,695 |
| Other Non-Current Assets | 238,226 | 248,654 | 257,580 | 264,684 | 279,174 |
| TOTAL | $5,181,635 | $5,212,944 | $5,244,616 | $5,258,060 | $5,335,522 |
| Total Assets | $6,355,563 | $6,304,328 | $6,226,873 | $6,306,566 | $6,437,155 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 75,080 | 86,713 | 74,916 | 63,583 | 84,167 |
| Accrued Expenses | 299,586 | 241,844 | 299,216 | 307,990 | 308,219 |
| Other current liabilities | 33,519 | 8,783 | 10,249 | 25,049 | 25,132 |
| TOTAL | $488,057 | $367,354 | $412,747 | $423,676 | $443,331 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 50,000 | 50,000 | 50,000 | 50,000 |
| Other Non-Current Liabilities | 2,810,884 | 2,829,266 | 2,720,964 | 2,724,256 | 2,734,478 |
| TOTAL | $2,810,884 | $2,879,266 | $2,770,964 | $2,774,256 | $2,784,478 |
| Total Liabilities | $3,298,941 | $3,246,620 | $3,183,711 | $3,197,932 | $3,227,809 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 180,665 | 180,388 | 178,217 | 177,684 | 176,960 |
| Common Shares | 1,806 | 1,799 | 1,780 | 1,774 | 1,769 |
| Retained earnings | -3,420,203 | -3,339,177 | -3,265,026 | -3,137,281 | -2,988,520 |
| Other shareholders' equity | -723 | -1,719 | -5,236 | -11,070 | -8,645 |
| TOTAL | $3,056,622 | $3,057,708 | $3,043,162 | $3,108,634 | $3,209,346 |
| Total Liabilities And Equity | $6,355,563 | $6,304,328 | $6,226,873 | $6,306,566 | $6,437,155 |